Gls-010, A Novel Anti-Pd-1 Mab In Chinese Patients With Relapsed Or Refractory Classical Hodgkin'S Lymphoma: Preliminary Result Of A Phase Ii Clinical Trial.

JOURNAL OF CLINICAL ONCOLOGY(2019)

引用 3|浏览57
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要